AIMed: Artificial Intelligence in Medicine 2026 is an annual conference organized by the Polish Institute for Evidence Based Medicine (PIEBM) / Polski Instytut Evidence Based Medicine, McMaster University Department of Medicine, Jagiellonian University Medical College and will be held from May 07 - 09, 2026 at ICE Krakow Congress Centre, Krakow, Lesser Poland, Poland and online.
What's included
Note:
Buy this conference and get below two conferences for free!!
Clinical AI in Practice will highlight the current state of the art in clinical applications of AI, examining how intelligent systems are being integrated into patient care, diagnostics, and hospital operations. Discussions will cover real-world deployment, clinical adoption trends, regulatory and policy frameworks, and the patient perspective on the use of AI in healthcare. Speakers will include clinicians, healthcare administrators, regulators, and representatives from patient organizations, offering a balanced and multidisciplinary view of how AI is transforming medicine today.
OPENING TALK
Marta Kwiatkowska MSc MA PhD
Professor of Computing Systems and Fellow of Trinity College, University of Oxford (United Kingdom)
To be announced
Nadeem Sarwar PhD
Senior Vice President, Global Head, Disease Prevention & Global Head, Metabolic Disease Strategy of Enveda; Honorary Professor, School of Medicine, University of Edinburgh (United Kingdom)
To be announced
Holger J. Schünemann MD MSc PhD
Professor of Public Health and Preventive Medicine at Humanitas University, Milan (Italy); Chair and co-founder of the GRADE Working Group
From hype to health: Methodological framework for trustworthy AI in clinical guideline development
Artur Nowak MSc
Co-Founder and CTO at Evidence Prime
Engineering the next generation of EBM tools: Using LLMs to augment expert analysis and empower patient participation
Bright Huo MD
McMaster University (Canada)
Evaluating health advice from generative AI: How do I do it, and what is the current landscape
Dan Perri MD
Associate Professor, Department of Medicine, McMaster University (Canada)
Closing the proof-of-concept-to-production gap: AI strategy and evidence are essential in the ICU
Thomas Lüscher MD
President of the European Society of Cardiology; Director of Research, Education & Development and Consulting Cardiologist at the Royal Brompton & Harefield Hospital Trust and Professor of Cardiology at the Imperial College in London (United Kingdom);
Director of the Center for Molecular Cardiology at the University Zurich (Switzerland)
AI in cardiology: From innovation to implementation
Julian Dobranowski MD
Professor and Chair, Department of Medical Imaging, McMaster University (Canada)
AI in radiology: Challenges and opportunities. We are still here.
Sameer Shaikh MD
Assistant Clinical Professor, Department of Medicine, McMaster University (Canada); CEO, Inflective AI
From classroom to clinic: Building the competency framework for an AI-enabled medical workforce
Advances in AI will showcase the latest technical breakthroughs and emerging frontiers in artificial intelligence. Talks will explore topics such as foundation models, multimodal learning, generative AI, explainability, robustness, and scalability. Speakers, world-renowned AI scientists and innovators, will review key methodological advances and discuss the ongoing challenges facing AI, including data limitations, generalizability, and ethical considerations.
Piotr Sankowski PhD
Professor, University of Warsaw (Poland); Director, IDEAS Research Institute
To be announced
Kostas Marias MSc PhD
Professor of Medical Image Processing, Department of Electrical & Computer Engineering,
Hellenic Mediterranean University (Greece); Head, Computational BioMedicine Laboratory (CBML), Institute of Computer Science, Foundation for Research & Technology – Hellas (FORTH-ICS)
What’s next in AI for precision oncology
Andreas Maier PhD
Professor and Head, Pattern Recognition Lab, Friedrich-Alexander-Universität Erlangen-Nürnberg (Germany)
What next in medical AI?
Petra Ritter MD PhD
Professor for Brain Simulation, BIH & Charité Universitätsmedizin Berlin; Director for International Affairs at Charité; Lead, European Testing and Experimentation Facility for Health AI and Robotics (TEF-Health)
AI testing and experimentation facility for health AI and robotics (TEF-Health)
Gary Collins PhD
Professor of Medical Statistics, University of Birmingham (United Kingdom); TRIPOD Steering Group
Inside black box: Transparent reporting for AI for healthcare
OPENING TALK
Emer Cooke MSc MBA
Executive Director, European Medicines Agency
To be announced
Karl Broich MD PhD
President, Federal Institute for Drugs and Medical Devices (Germany);
Honorary Professor for Psychiatry and Clinical Neuropsycopharmacology, University of Bonn (Germany)
To be announced
Ricardo Baptista Leite MD
CEO, HealthAI – The Global Agency for Responsible AI in Health (Switzerland)
HEALTH AI: The Global Agency for Responsible AI in Health
Aneta Tyszkiewicz MA
Director, Data Digital, European Federation of Pharmaceutical Industries and Associations
Building trust and understanding in AI use in the medicine lifecycle – Company practices
Angeliki Kerasidou MA, DPhil
Associate Professor in Bioethics, Ethox Centre, University of Oxford (United Kingdom)
AI, trust and future provision of health care
Rebecca Brendel MD JD
Assistant Professor in Psychiatry, Harvard Medical School; Director, Center for Bioethics, Harvard Medical School (USA)
Dimensions of responsibility in AI in medicine
Terms & Disclaimers:
1. Participation in MIRCIM, AIMed, and Young Talents is paid. Registering for any one of these events grants access to all three. The pricing details are available on the respective event websites.
2. In-person participation includes:
a. access to all sessions on Day 1, Day 2, and Day 3 of MIRCIM, AIMed, and Young Talents;
b. complimentary access to live streaming;
c. on-demand access to video recordings from the conferences for 12 months;
d. on-site exhibits;
e. access to posters from the Young Talents in Internal Medicine World Contest in the exhibit hall;
f. access to posters from the AIMed conference in the exhibit hall;
g. conference materials (PDF);
h. refreshments; lunch on Day 1, Day 2, and Day 3 (available for an additional fee);
i. certificate of attendance;
3. Virtual participation includes:
a. live stream access to all sessions on Day 1, Day 2, and Day 3 of MIRCIM, AIMed, and Young Talents;
b. on-demand access to video recordings from the conferences;
c. access to abstracts and posters from the Young Talents in Internal Medicine World Contest;
d. access to abstracts and posters from AIMed conference;
e. conference materials (PDF);
f. certificate of attendance.
4. Participants can receive educational credits for participation in MIRCIM and Young Talents under the rules established by the European Accreditation Council for Continuing Medical Education (UEMS-EACCME®). The condition for receiving the certificate and EACCME® credits is the purchase of access to and participation in MIRCIM and Young Talents (in-person or virtual) as well as submission of a filled-in evaluation questionnaire within 6 months following the event; the questionnaire shall be made available on the Virtual Platform.The maximum number of credits that can be awarded for participation in MIRCIM and Young Talents will be determined by a separate EACCME® resolution and will be announced on the MIRCIM Website.
5. Participants can withdraw their participation. Cancellations can be made prior to Day 1 of the Events and should be reported in writing to support@emedevents.com.
6. The following shall apply to withdrawal of paid participation:
a) if PIEBM receives a declaration of withdrawal from the Participant between January 1 to March 31, 2026, the Participant shall receive a partial refund of 50% of the paid participation fee;
b) after April 1, 2026 the participation fee is nonrefundable;
c) PIEBM shall have 30 days to refund the payment once the Participant has met all the requirements for submitting the withdrawal to the address support@emedevents.com
d) the refund will be made to the original payer and with the same method of payment used for purchase.
7. The Participant must participate in the Events in a way that does not hinder or interfere with the conduct of the Events. The Participant must not undertake any actions that (a) are against the provisions of generally applicable law or good practice, (b) are in violation of other Participants’ rights of publicity, or (c) violate the legitimate interests of organizers or other Participants.
8. To maintain safety, Participants are asked to comply with the health and safety rules and regulations.
9. The organizers reserve the right to modify the Events program at any time. Program changes are not acceptable grounds for requesting a refund.
10. Participants agree to receive information about the Events via email.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved